Purigen Biosystems Revenue and Competitors

Location

$93.1M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Purigen Biosystems's estimated annual revenue is currently $1M per year.(i)
  • Purigen Biosystems's estimated revenue per employee is $77,500
  • Purigen Biosystems's total funding is $93.1M.

Employee Data

  • Purigen Biosystems has 13 Employees.(i)
  • Purigen Biosystems grew their employee count by -62% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$1.1M70%N/AN/A
#4
$2.3M15150%N/AN/A
#5
$1.4M90%N/AN/A
#6
$11.5M74-12%N/AN/A
#7
$0.4M27510%$236.7MN/A
#8
$4M51-74%$160MN/A
#9
$2.5M1633%N/AN/A
#10
$3.3M21-12%N/AN/A
Add Company

Purigen Biosystems'? transformative platform provides a hands-free solution for extracting, enriching and quantifying DNA and RNA from biological samples. Our proprietary approach uses isotachophoresis (ITP), an electric-field-driven technique for purifying, focusing, and/or separating species. The application of ITP to purify and quantify nucleic acids from complex biological samples was pioneered by Purigen co-founder, Stanford Professor Juan G. Santiago. Purigen's system is compatible with a range of samples. This includes mammalian cells, FFPE and FNA tissue biopsies, plasma, blood, and buccal swabs.

keywords:N/A

$93.1M

Total Funding

13

Number of Employees

$1M

Revenue (est)

-62%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Purigen Biosystems News

2022-04-13 - Purigen Launches Ionic® Cells to Pure DNA Kit for White ...

--(BUSINESS WIRE)--Purigen Biosystems, Inc., a leading provider of next-generation technologies for extracting and purifying nucleic acids from...

2022-04-06 - Purigen Biosystems Expands Commercial Presence in ...

The Ionic® Purification System from Purigen Biosystems enables researchers to extract higher yields of purified DNA and RNA from challenging...

2019-06-12 - Purigen Biosystems Closes $26.4M Series B Financing

Purigen Biosystems, Inc., a Pleasanton, Calif.-based provider of next-generation technologies for extracting, enriching, and quantifying nucleic acids from biological samples, closed a $26.4m Series B financing. The round was led by Agilent Technologies with participation from new investor Cota ...

2016-05-17 - Purigen Biosystems Completes $18.2M Series A Funding

Purigen Biosystems, a Pleasanton, CA-based developer of technology for genomics sample preparation, completed an $18.2M Series A funding. Backers included 5AM Ventures, Roche Venture Fund and existing investors the Stanford-Startx Fund and Western Investments Capital. Under the terms of the fin ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M1386%N/A
#2
$3.3M138%N/A
#3
$1.9M130%N/A
#4
$1M1417%N/A
#5
N/A14N/AN/A